Oxford Endovascular
Generated by Meeveem AI
"Preventing brain haemorrhage through origami engineered flow diverter technology"
Oxford
•1 - 10 Employees
•Medical Devices
About Oxford Endovascular
Oxford Endovascular develops OxiFlow, a next generation flow diverter designed to prevent brain haemorrhage by treating intracranial aneurysms. Spun out from Oxford University, the device uses origami engineering to place more accurately and safely than existing solutions, conforming better to blood vessels to make more patients treatable. One in 50 people are affected by brain aneurysms at risk of rupture. Invented by a world renowned physician and an origami engineering expert, OxiFlow holds patents across Europe, the US, China and Japan. The company has raised over $28 million including a Horizon 2020 grant from the European Union. Oxford Endovascular addresses unmet clinical needs in a rapidly growing market valued at over $1 billion.
9
Team Members
2015
Founded
Medical Devices
Sector
On-Site
Work Environment
Our Vision
A world where brain haemorrhage from aneurysms is preventable through accessible, safe, and reliable treatment available to every patient who needs it.
Our Mission
Oxford Endovascular develops next generation flow diverter technology to prevent brain haemorrhage by treating intracranial aneurysms more accurately and safely than existing devices.